Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874) Cyclically Adjusted Book per Share: HK$13.03 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00874 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd HKSE:00874
90 GF Score
Price HK$15.13
GF Value HK$22.26
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share?

Guangzhou Baiyunshan Pharmaceutical Holdings Co HKSE:00874 -0.85% 90 Cyclically Adjusted Book per Share is HK$13.03 as of Mar. 2026. GuruFocus rates HKSE:00874 with a GF Score™ of 90/100 and a GF Value™ of HK$22.26 (Significantly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's adjusted book value per share for the three months ended in Mar. 2026 was HK$27.633. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is HK$13.03 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average Cyclically Adjusted Book Growth Rate was 11.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 12.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 15.20% per year. The lowest was 5.20% per year. And the median was 12.20% per year.

As of today (2026-08-15), Guangzhou Baiyunshan Pharmaceutical Holdings Co's current stock price is HK$15.13. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was HK$13.03. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio of today is 1.16.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 6.45. The lowest was 1.11. And the median was 2.92.


Guangzhou Baiyunshan Pharmaceutical Holdings Co  (HKSE:00874) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=15.13/13.03
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 6.45. The lowest was 1.11. And the median was 2.92.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share Related Terms


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.23 9.64 10.64 9.96 11.94

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.28 10.81 12.01 11.94 13.03

HKSE:00874 vs MCK, COR, CAH: Cyclically Adjusted Book per Share Comparison

For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted PB Ratio falls into.


HKSE:00874
90GF Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd HKSE:00874
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Baiyunshan Pharmaceutical Holdings Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guangzhou Baiyunshan Pharmaceutical Holdings Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=27.633/116.3033*116.3033
=27.633

Current CPI (Mar. 2026) = 116.3033.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 8.478 101.400 9.724
201609 12.433 102.400 14.121
201612 11.962 102.600 13.560
201703 12.356 103.200 13.925
201706 12.718 103.100 14.347
201709 13.441 104.100 15.017
201712 13.752 104.500 15.305
201803 15.097 105.300 16.675
201806 15.581 104.900 17.275
201809 15.247 106.600 16.635
201812 15.151 106.500 16.546
201903 16.611 107.700 17.938
201906 16.429 107.700 17.741
201909 16.365 109.800 17.334
201912 16.553 111.200 17.313
202003 17.263 112.300 17.878
202006 16.823 110.400 17.723
202009 18.109 111.700 18.855
202012 19.063 111.500 19.884
202103 20.371 112.662 21.029
202106 20.633 111.769 21.470
202109 21.185 112.215 21.957
202112 21.888 113.108 22.506
202203 23.409 114.335 23.812
202206 22.020 114.558 22.356
202209 21.617 115.339 21.798
202212 22.025 115.116 22.252
202303 23.797 115.116 24.043
202306 22.663 114.558 23.008
202309 22.869 115.339 23.060
202312 23.493 114.781 23.805
202403 24.641 115.227 24.871
202406 24.012 114.781 24.330
202409 24.531 115.785 24.641
202412 23.579 114.893 23.869
202503 24.876 115.116 25.133
202506 25.387 114.907 25.695
202509 25.480 115.471 25.664
202512 25.677 115.832 25.781
202603 27.633 116.303 27.633

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of HK$13.03 mean?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874) has a Cyclically Adjusted Book per Share of HK$13.03 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Cyclically Adjusted Book per Share is HK$13.03. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share compare to MCK and COR?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cyclically Adjusted Book per Share of HK$13.03 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Distribution company?
A good Cyclically Adjusted Book per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Cyclically Adjusted Book per Share is HK$13.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$22.26, compared to a current price of HK$15.13 — trading 32% below its estimated fair value. The current Cyclically Adjusted Book per Share is HK$13.03. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874), the current Cyclically Adjusted Book per Share is HK$13.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of HK$15.13 is trading 32% below its estimated GF Value™ of HK$22.26. GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Significantly Undervalued.

Key valuation signals for HKSE:00874:

  • Cyclically Adjusted Book per Share: HK$13.03
  • GF Value™: HK$22.26 vs. price of HK$15.13 (32% below fair value)
  • GF Score™: 90/100 with 6 warning signs

No single metric tells the full story. See the HKSE:00874 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Other Exchanges GU5:Germany600332:China
Address 45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
90GF Score

Get the complete analysis for HKSE:00874

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$15.13
Price
HK$22.26
GF Value